Suppression of ruffling by the EGF receptor in chemotactic cells.
To clarify the relationship between ruffling and lamellipod extension in growth factor-stimulated chemotactic responses, we utilized cell lines derived from the rat 13762 NF mammary adenocarcinoma. Nonmetastatic MTC cells expressing the human EGF receptor (termed MTC HER cells) demonstrated chemotactic responses to TGF-alpha, an EGF receptor ligand typically present in mammary tissue. In microchemotaxis chambers, peak chemotactic responses occurred in response to 5 nM TGF-alpha. MTC HER cells showed dramatic ruffling edges in the absence of external stimuli, and addition of 5 nM TGF-alpha led to a transient reduction in ruffling concomitant with lamellipod extension. Lamellipod extension correlated with an overall increase in actin polymerization. These responses were blocked by the PI 3 kinase inhibitor wortmannin but not by the MAP kinase inhibitors PD98059 and SB203580. We conclude that the initial chemotactic response to TGF-alpha involves lamellipod extension and that ruffling reflects a dynamic turnover of lamellipodia that is arrested during lamellipod extension. By regulating the dissolution of ruffles and extension of lamellipods, a chemotactic response can be achieved, which may contribute to the metastatic process.
Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
J B
JB
Wyckoff
L
L
Insel
K
K
Khazaie
R B
RB
Lichtner
J S
JS
Condeelis
J E
JE
Segall
D000199:Actins / Q000096:biosynthesis; D000230:Adenocarcinoma; D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors; D002462:Cell Membrane / Q000648:ultrastructure*; D002630:Chemotactic Factors / Q000494:pharmacology; D002633:Chemotaxis / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D066246:ErbB Receptors / Q000235:genetics / Q000502:physiology*; D006801:Humans; D008325:Mammary Neoplasms, Experimental; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011554:Pseudopodia / Q000502:physiology* / Q000648:ultrastructure; D051381:Rats; D016211:Transforming Growth Factor alpha / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D000077191:Wortmannin
D000199:Actins; D000730:Androstadienes; D002630:Chemotactic Factors; D004791:Enzyme Inhibitors; D000081082:Phosphoinositide-3 Kinase Inhibitors; D016211:Transforming Growth Factor alpha; D066246:ErbB Receptors; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D000077191:Wortmannin